Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention (PacTAP Study): A Double Blind, Randomized Control Study

NCT01599078 is registered in ClinicalTrials.gov with Midwest Cardiovascular Research Foundation as lead sponsor.

NCT NCT01599078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01599078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention (PacTAP Study): A Double Blind, Randomized Control Study
Lead sponsor
Midwest Cardiovascular Research Foundation
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2012
Completion date
January 31, 2014
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, restenosis